nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Pain—Irinotecan—lung cancer	0.000673	0.000673	CcSEcCtD
Cefuroxime—Arthralgia—Paclitaxel—lung cancer	0.000669	0.00067	CcSEcCtD
Cefuroxime—Chest pain—Paclitaxel—lung cancer	0.000669	0.00067	CcSEcCtD
Cefuroxime—Erythema—Docetaxel—lung cancer	0.000666	0.000667	CcSEcCtD
Cefuroxime—Decreased appetite—Gemcitabine—lung cancer	0.000666	0.000667	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000665	0.000665	CcSEcCtD
Cefuroxime—Nausea—Topotecan—lung cancer	0.000662	0.000663	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000662	0.000662	CcSEcCtD
Cefuroxime—Pain—Gemcitabine—lung cancer	0.000655	0.000656	CcSEcCtD
Cefuroxime—Nausea—Erlotinib—lung cancer	0.000655	0.000656	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—lung cancer	0.000655	0.000655	CcSEcCtD
Cefuroxime—Anaphylactic shock—Etoposide—lung cancer	0.000654	0.000655	CcSEcCtD
Cefuroxime—Diarrhoea—Vinorelbine—lung cancer	0.000653	0.000653	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000651	0.000651	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—lung cancer	0.000647	0.000647	CcSEcCtD
Cefuroxime—Neutropenia—Methotrexate—lung cancer	0.000645	0.000645	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—lung cancer	0.000645	0.000645	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Irinotecan—lung cancer	0.000643	0.000644	CcSEcCtD
Cefuroxime—Anaphylactic shock—Paclitaxel—lung cancer	0.000642	0.000642	CcSEcCtD
Cefuroxime—Thrombocytopenia—Etoposide—lung cancer	0.000641	0.000641	CcSEcCtD
Cefuroxime—Muscle spasms—Docetaxel—lung cancer	0.000641	0.000641	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—lung cancer	0.000641	0.000641	CcSEcCtD
Cefuroxime—Tachycardia—Etoposide—lung cancer	0.000639	0.000639	CcSEcCtD
Cefuroxime—Dyspnoea—Cisplatin—lung cancer	0.000637	0.000637	CcSEcCtD
Cefuroxime—Skin disorder—Etoposide—lung cancer	0.000636	0.000636	CcSEcCtD
Cefuroxime—Hyperhidrosis—Etoposide—lung cancer	0.000633	0.000633	CcSEcCtD
Cefuroxime—Dizziness—Vinorelbine—lung cancer	0.000631	0.000631	CcSEcCtD
Cefuroxime—Thrombocytopenia—Paclitaxel—lung cancer	0.000628	0.000629	CcSEcCtD
Cefuroxime—Tachycardia—Paclitaxel—lung cancer	0.000626	0.000627	CcSEcCtD
Cefuroxime—Anorexia—Etoposide—lung cancer	0.000624	0.000624	CcSEcCtD
Cefuroxime—Skin disorder—Paclitaxel—lung cancer	0.000623	0.000624	CcSEcCtD
Cefuroxime—Abdominal pain—Irinotecan—lung cancer	0.000622	0.000622	CcSEcCtD
Cefuroxime—Body temperature increased—Irinotecan—lung cancer	0.000622	0.000622	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000622	0.000622	CcSEcCtD
Cefuroxime—Decreased appetite—Cisplatin—lung cancer	0.000621	0.000621	CcSEcCtD
Cefuroxime—Hyperhidrosis—Paclitaxel—lung cancer	0.00062	0.000621	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Cisplatin—lung cancer	0.000617	0.000617	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—lung cancer	0.000615	0.000615	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—lung cancer	0.000615	0.000615	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—lung cancer	0.000615	0.000615	CcSEcCtD
Cefuroxime—Anorexia—Paclitaxel—lung cancer	0.000612	0.000612	CcSEcCtD
Cefuroxime—Pain—Cisplatin—lung cancer	0.000611	0.000611	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000609	0.00061	CcSEcCtD
Cefuroxime—Vomiting—Vinorelbine—lung cancer	0.000607	0.000607	CcSEcCtD
Cefuroxime—Body temperature increased—Gemcitabine—lung cancer	0.000606	0.000606	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—lung cancer	0.000604	0.000605	CcSEcCtD
Cefuroxime—Rash—Vinorelbine—lung cancer	0.000601	0.000602	CcSEcCtD
Cefuroxime—Dermatitis—Vinorelbine—lung cancer	0.000601	0.000601	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—lung cancer	0.000599	0.000599	CcSEcCtD
Cefuroxime—Headache—Vinorelbine—lung cancer	0.000598	0.000598	CcSEcCtD
Cefuroxime—Leukopenia—Docetaxel—lung cancer	0.000596	0.000597	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—lung cancer	0.000591	0.000591	CcSEcCtD
Cefuroxime—Sweating—Methotrexate—lung cancer	0.000589	0.00059	CcSEcCtD
Cefuroxime—Palpitations—Docetaxel—lung cancer	0.000589	0.000589	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000585	0.000585	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—lung cancer	0.000583	0.000584	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—lung cancer	0.000582	0.000582	CcSEcCtD
Cefuroxime—Cough—Docetaxel—lung cancer	0.000581	0.000582	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—lung cancer	0.000581	0.000582	CcSEcCtD
Cefuroxime—Hypersensitivity—Irinotecan—lung cancer	0.00058	0.00058	CcSEcCtD
Cefuroxime—Convulsion—Docetaxel—lung cancer	0.000577	0.000578	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—lung cancer	0.000574	0.000574	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—lung cancer	0.000574	0.000574	CcSEcCtD
Cefuroxime—Dyspnoea—Paclitaxel—lung cancer	0.000572	0.000572	CcSEcCtD
Cefuroxime—Somnolence—Paclitaxel—lung cancer	0.00057	0.000571	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—lung cancer	0.000569	0.000569	CcSEcCtD
Cefuroxime—Arthralgia—Docetaxel—lung cancer	0.000567	0.000568	CcSEcCtD
Cefuroxime—Chest pain—Docetaxel—lung cancer	0.000567	0.000568	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—lung cancer	0.000567	0.000567	CcSEcCtD
Cefuroxime—Nausea—Vinorelbine—lung cancer	0.000567	0.000567	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—lung cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Dyspepsia—Paclitaxel—lung cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Body temperature increased—Cisplatin—lung cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000563	0.000564	CcSEcCtD
Cefuroxime—Pain—Etoposide—lung cancer	0.00056	0.00056	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—lung cancer	0.000558	0.000558	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—lung cancer	0.000558	0.000558	CcSEcCtD
Cefuroxime—Decreased appetite—Paclitaxel—lung cancer	0.000558	0.000558	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000555	0.000555	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—lung cancer	0.000555	0.000555	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000554	0.000554	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—lung cancer	0.000552	0.000552	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—lung cancer	0.000552	0.000552	CcSEcCtD
Cefuroxime—Pain—Paclitaxel—lung cancer	0.000549	0.000549	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—lung cancer	0.000545	0.000545	CcSEcCtD
Cefuroxime—Anaphylactic shock—Docetaxel—lung cancer	0.000544	0.000544	CcSEcCtD
Cefuroxime—Pruritus—Gemcitabine—lung cancer	0.000542	0.000543	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—lung cancer	0.000541	0.000541	CcSEcCtD
Cefuroxime—Diarrhoea—Irinotecan—lung cancer	0.000538	0.000539	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—lung cancer	0.000535	0.000535	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—lung cancer	0.000532	0.000533	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—lung cancer	0.000532	0.000533	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—lung cancer	0.000532	0.000533	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—lung cancer	0.000532	0.000533	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—lung cancer	0.000531	0.000531	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—lung cancer	0.000528	0.000529	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000528	0.000528	CcSEcCtD
Cefuroxime—Hypersensitivity—Cisplatin—lung cancer	0.000526	0.000527	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Paclitaxel—lung cancer	0.000525	0.000525	CcSEcCtD
Cefuroxime—Diarrhoea—Gemcitabine—lung cancer	0.000524	0.000525	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—lung cancer	0.000523	0.000523	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—lung cancer	0.000522	0.000522	CcSEcCtD
Cefuroxime—Dizziness—Irinotecan—lung cancer	0.00052	0.000521	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—lung cancer	0.00052	0.00052	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—lung cancer	0.000519	0.000519	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—lung cancer	0.000519	0.000519	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—lung cancer	0.000518	0.000519	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—lung cancer	0.000517	0.000518	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—lung cancer	0.000517	0.000518	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—lung cancer	0.000517	0.000518	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—lung cancer	0.00051	0.000511	CcSEcCtD
Cefuroxime—Urticaria—Paclitaxel—lung cancer	0.00051	0.00051	CcSEcCtD
Cefuroxime—Abdominal pain—Paclitaxel—lung cancer	0.000507	0.000508	CcSEcCtD
Cefuroxime—Body temperature increased—Paclitaxel—lung cancer	0.000507	0.000508	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—lung cancer	0.000503	0.000504	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—lung cancer	0.000501	0.000501	CcSEcCtD
Cefuroxime—Vomiting—Irinotecan—lung cancer	0.0005	0.000501	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—lung cancer	0.000499	0.0005	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—lung cancer	0.000498	0.000499	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—lung cancer	0.000497	0.000497	CcSEcCtD
Cefuroxime—Rash—Irinotecan—lung cancer	0.000496	0.000496	CcSEcCtD
Cefuroxime—Dermatitis—Irinotecan—lung cancer	0.000496	0.000496	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000495	0.000496	CcSEcCtD
Cefuroxime—Chills—Methotrexate—lung cancer	0.000495	0.000495	CcSEcCtD
Cefuroxime—Headache—Irinotecan—lung cancer	0.000493	0.000493	CcSEcCtD
Cefuroxime—Diarrhoea—Cisplatin—lung cancer	0.000489	0.000489	CcSEcCtD
Cefuroxime—Vomiting—Gemcitabine—lung cancer	0.000487	0.000488	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—lung cancer	0.000485	0.000485	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—lung cancer	0.000483	0.000484	CcSEcCtD
Cefuroxime—Rash—Gemcitabine—lung cancer	0.000483	0.000484	CcSEcCtD
Cefuroxime—Dermatitis—Gemcitabine—lung cancer	0.000483	0.000483	CcSEcCtD
Cefuroxime—Hypersensitivity—Etoposide—lung cancer	0.000482	0.000482	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—lung cancer	0.00048	0.000481	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—lung cancer	0.00048	0.00048	CcSEcCtD
Cefuroxime—Headache—Gemcitabine—lung cancer	0.00048	0.00048	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—lung cancer	0.000479	0.000479	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—lung cancer	0.000478	0.000478	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—lung cancer	0.000478	0.000478	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—lung cancer	0.000473	0.000473	CcSEcCtD
Cefuroxime—Hypersensitivity—Paclitaxel—lung cancer	0.000473	0.000473	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—lung cancer	0.000472	0.000472	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—lung cancer	0.00047	0.00047	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—lung cancer	0.000468	0.000469	CcSEcCtD
Cefuroxime—Nausea—Irinotecan—lung cancer	0.000467	0.000468	CcSEcCtD
Cefuroxime—Pain—Docetaxel—lung cancer	0.000465	0.000465	CcSEcCtD
Cefuroxime—Pruritus—Etoposide—lung cancer	0.000463	0.000463	CcSEcCtD
Cefuroxime—Nausea—Gemcitabine—lung cancer	0.000455	0.000455	CcSEcCtD
Cefuroxime—Vomiting—Cisplatin—lung cancer	0.000454	0.000454	CcSEcCtD
Cefuroxime—Pruritus—Paclitaxel—lung cancer	0.000454	0.000454	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—lung cancer	0.000452	0.000452	CcSEcCtD
Cefuroxime—Rash—Cisplatin—lung cancer	0.00045	0.000451	CcSEcCtD
Cefuroxime—Dermatitis—Cisplatin—lung cancer	0.00045	0.00045	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—lung cancer	0.000448	0.000448	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Docetaxel—lung cancer	0.000445	0.000445	CcSEcCtD
Cefuroxime—Diarrhoea—Paclitaxel—lung cancer	0.000439	0.000439	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—lung cancer	0.000433	0.000434	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—lung cancer	0.000433	0.000433	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—lung cancer	0.000432	0.000432	CcSEcCtD
Cefuroxime—Body temperature increased—Docetaxel—lung cancer	0.00043	0.00043	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—lung cancer	0.00043	0.00043	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—lung cancer	0.00043	0.00043	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—lung cancer	0.000429	0.000429	CcSEcCtD
Cefuroxime—Dizziness—Paclitaxel—lung cancer	0.000424	0.000425	CcSEcCtD
Cefuroxime—Nausea—Cisplatin—lung cancer	0.000424	0.000425	CcSEcCtD
Cefuroxime—Cough—Methotrexate—lung cancer	0.000419	0.000419	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—lung cancer	0.000416	0.000416	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—lung cancer	0.000416	0.000416	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—lung cancer	0.000416	0.000416	CcSEcCtD
Cefuroxime—Rash—Etoposide—lung cancer	0.000413	0.000413	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—lung cancer	0.000412	0.000412	CcSEcCtD
Cefuroxime—Headache—Etoposide—lung cancer	0.00041	0.00041	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—lung cancer	0.00041	0.00041	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—lung cancer	0.000409	0.000409	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—lung cancer	0.000409	0.000409	CcSEcCtD
Cefuroxime—Vomiting—Paclitaxel—lung cancer	0.000408	0.000408	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000406	0.000406	CcSEcCtD
Cefuroxime—Rash—Paclitaxel—lung cancer	0.000405	0.000405	CcSEcCtD
Cefuroxime—Dermatitis—Paclitaxel—lung cancer	0.000404	0.000404	CcSEcCtD
Cefuroxime—Headache—Paclitaxel—lung cancer	0.000402	0.000402	CcSEcCtD
Cefuroxime—Hypersensitivity—Docetaxel—lung cancer	0.000401	0.000401	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—lung cancer	0.0004	0.0004	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—lung cancer	0.000392	0.000392	CcSEcCtD
Cefuroxime—Nausea—Etoposide—lung cancer	0.000389	0.000389	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—lung cancer	0.000385	0.000385	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—lung cancer	0.000384	0.000384	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—lung cancer	0.000382	0.000382	CcSEcCtD
Cefuroxime—Nausea—Paclitaxel—lung cancer	0.000381	0.000381	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—lung cancer	0.000381	0.000381	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—lung cancer	0.000379	0.000379	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—lung cancer	0.000374	0.000374	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—lung cancer	0.000372	0.000372	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—lung cancer	0.000372	0.000372	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—lung cancer	0.000368	0.000368	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—lung cancer	0.000363	0.000363	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—lung cancer	0.00036	0.000361	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—lung cancer	0.00036	0.00036	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000357	0.000357	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—lung cancer	0.000354	0.000354	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—lung cancer	0.000354	0.000354	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000352	0.000352	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—lung cancer	0.000349	0.00035	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—lung cancer	0.000348	0.000349	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—lung cancer	0.000346	0.000346	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—lung cancer	0.000345	0.000345	CcSEcCtD
Cefuroxime—Rash—Docetaxel—lung cancer	0.000343	0.000343	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—lung cancer	0.000343	0.000343	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—lung cancer	0.000341	0.000341	CcSEcCtD
Cefuroxime—Headache—Docetaxel—lung cancer	0.000341	0.000341	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—lung cancer	0.000339	0.00034	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—lung cancer	0.000338	0.000339	CcSEcCtD
Cefuroxime—Pain—Methotrexate—lung cancer	0.000335	0.000335	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—lung cancer	0.000332	0.000333	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—lung cancer	0.000331	0.000331	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—lung cancer	0.00033	0.00033	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—lung cancer	0.000328	0.000328	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—lung cancer	0.000324	0.000324	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—lung cancer	0.000323	0.000323	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—lung cancer	0.000321	0.000321	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—lung cancer	0.000311	0.000312	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—lung cancer	0.00031	0.00031	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—lung cancer	0.00031	0.00031	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000309	0.000309	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—lung cancer	0.000303	0.000303	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—lung cancer	0.000302	0.000302	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—lung cancer	0.000299	0.000299	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—lung cancer	0.000295	0.000295	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000293	0.000293	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—lung cancer	0.00029	0.00029	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—lung cancer	0.000289	0.000289	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—lung cancer	0.000278	0.000278	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—lung cancer	0.000277	0.000277	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—lung cancer	0.00027	0.00027	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—lung cancer	0.000268	0.000268	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—lung cancer	0.000268	0.000268	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—lung cancer	0.000268	0.000268	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—lung cancer	0.000259	0.000259	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—lung cancer	0.00025	0.00025	CcSEcCtD
Cefuroxime—Vomiting—Methotrexate—lung cancer	0.000249	0.000249	CcSEcCtD
Cefuroxime—Rash—Methotrexate—lung cancer	0.000247	0.000247	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—lung cancer	0.000247	0.000247	CcSEcCtD
Cefuroxime—Headache—Methotrexate—lung cancer	0.000246	0.000246	CcSEcCtD
Cefuroxime—Cefonicid—ALB—lung cancer	0.000245	0.369	CrCbGaD
Cefuroxime—Pruritus—Doxorubicin—lung cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—lung cancer	0.000233	0.000233	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—lung cancer	0.000232	0.000232	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—lung cancer	0.000224	0.000225	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—lung cancer	0.000216	0.000216	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—lung cancer	0.000214	0.000214	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—lung cancer	0.000214	0.000214	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—lung cancer	0.000213	0.000213	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—lung cancer	0.000202	0.000202	CcSEcCtD
Cefuroxime—Cefazolin—ALB—lung cancer	0.000119	0.179	CrCbGaD
Cefuroxime—Ceftriaxone—ALB—lung cancer	0.000113	0.169	CrCbGaD
Cefuroxime—Cefalotin—ALB—lung cancer	9.86e-05	0.148	CrCbGaD
Cefuroxime—Cephalexin—ALB—lung cancer	8.96e-05	0.135	CrCbGaD
